SCHEMBL18669233

SCHEMBL18669233

O=C1c2ccccc2C(=O)N1Cc1cc(C(F)(F)F)ccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 4/20 0.50
TRAP1 Q12931 3/20 0.50
CHRM3 P20309 1/20 0.50
GRM5 P41594 1/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
HSP90AA1 P07900 1/20 0.45
HSP90B1 P14625 1/20 0.45
TYR P14679 1/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CA1 P00915 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18669196 0.86 KDM4E (0.54) CHRM5TRAP1CHRM3HSP90AA1HSP90B1
SCHEMBL18669001 0.84 CA9 (0.55) CHRM5CHRM3GRM5ADRA1DADRA1A
SCHEMBL18669206 0.81 CA1 (0.52) CHRM5TRAP1CHRM3GRM5MEN1
SCHEMBL31255159 0.81 GRM5 (0.46) CHRM5CHRM3GRM5ADRA1DADRA1A
SCHEMBL3729290 0.80 GRM5 (0.54) GRM5TYRHTTMEN1ALDH1A1
SCHEMBL17866111 0.79 KMT2A (0.56) ADRA1DADRA1AADRA1BHTTMEN1
SCHEMBL18669181 0.79 AHR (0.43) CHRM5TRAP1CHRM3GRM5ALDH1A1
SCHEMBL3729405 0.78 TYR (0.49) GRM5ADRA1DADRA1AADRA1BTYR
SCHEMBL13077677 0.78 RPS6KA2 (0.50) TYRHTTMEN1ALDH1A1GAA
SCHEMBL24827438 0.77 KMT2A (0.58) CHRM5CHRM3ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 WO disclosed
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 WO disclosed